SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-08-002326
Filing Date
2008-03-07
Accepted
2008-03-07 06:10:31
Documents
4
Period of Report
2008-04-22
Effectiveness Date
2008-03-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2183412zdef14a.htm DEF 14A 462273
2 G817752.JPG g817752.jpg GRAPHIC 3184
3 G979546.JPG g979546.jpg GRAPHIC 1817
4 G352051.JPG g352051.jpg GRAPHIC 2875
  Complete submission text file 0001047469-08-002326.txt   475070
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 08672553
SIC: 2834 Pharmaceutical Preparations